Text Size: A- A+ Facebook Twitter LinkedIn YouTube

Breaking News

Pledge the Gift of Life

Each year, the lives of thousands of people across the country are saved because someone made the choice to become an organ donor. In April, Allegheny Health Network is honored to celebrate National Donate Life Month and pay tribute to all of those who have bestowed the precious gift of life to another through organ donation. Visit AHNdonate.org to learn more and register to be an organ donor.



Format: 04/23/2014
Format: 04/23/2014


Tri-State Area Heart Specialists Convene To Learn About Breakthrough in Heart Assist Technology, Meet AGH Patients Whose Lives Have Been Saved by It

Thursday, March 25th, 2010

Who/What: Members of the Advanced Heart Failure Team from Allegheny General Hospital’s Gerald McGinnis Cardiovascular Institute will address a gathering of cardiologists from the tri-state area about the new Thoratec HeartMate II Left Ventricular Assist System. HeartMate II is the world’s first heart assist technology of its kind designed and approved by the FDA to be a permanent therapeutic alternative to heart transplantation for patients with advanced heart failure. 

HeartMate II is the first and only heart assist device that is a continuous flow system – meaning there is no pulse, but a continuous circulation of blood throughout the body. HeartMate II is extremely portable – weighing just 12 ounces, the size of a D-Cell battery and powered by a small battery pack worn over the shoulder.

AGH heart specialists helped lead the clinical investigation of HeartMate II, which led to its FDA approval

In addition to the AGH medical team, two patients will share their experience with the device, including;
• GS Gill, 70, of Morgantown. Mr. Gill has been traveling the country since receiving the device on a permanent basis.
• Richard Davies, 39, of Latrobe. Mr. Davies is using the device until a heart transplant is possible.

Where: Lidia’s Italy Restaurant
1400 Smallman Street, Strip District

When: Thursday, March 25, 2010, 6 p.m.- 8 p.m.

Why: Approximately 6 million Americans suffer from heart failure. The prognosis for patients with advanced disease is poor with one year mortality rates exceeding those of other terminal diseases such as AIDS, leukemia and lung cancer. Though heart transplantation offers hope for about 2,000 such patients each year, more than 250,000 have no viable treatment option. HeartMate II is believed to offer NEW HOPE for as many as 50,000-100,000 heart failure patients who are not considered good candidates for transplantation.


West Penn Allegheny Health System
Tell us who you are:

What areas do you use on our website?*
(select more than one if it applies)

Did you find what you were looking for?

Would you refer others to our website?

Can we contact you for future questions?

CAPTCHA math question:* 4 + 8 =

Thank you for completing the West Penn Allegheny Health System website survey.
We value your feedback and comments.